Alyssa Flores is a Founding Partner, Owner, President and Chief Executive Officer of Federal Commercialization Partners USA™ (FedCom™), a national organization focused on helping innovative medical technologies successfully enter and grow within federal healthcare markets.
As President and CEO, Alyssa leads the strategic direction, infrastructure and long-term growth of FedCom™, with a central focus on building a strong, scalable national sales channel within the federal healthcare market. Her leadership is centered on creating the relationships, sales organization and commercialization infrastructure necessary to bring innovative medical technologies to healthcare providers serving veterans, active-duty military personnel, federal employees, Tribal communities and other government-supported patient populations.
FedCom™ provides manufacturers with a dedicated pathway into federal healthcare through commercialization strategy, contracting support, national sales execution and strategic account development across the Department of Veterans Affairs (VA), Department of Defense (DoD), Department of Labor (DOL), Indian Health Service (IHS), Tribal Health organizations and other federal healthcare channels.
Alyssa is also the Founder and CEO of CSQ Bio®, a national medical distribution company focused on bringing innovative healthcare technologies and integrated medical solutions to commercial markets. Through CSQ Bio®, she has built relationships across manufacturers, healthcare providers, sales organizations and distribution networks, experience that helped shape the foundation for FedCom™.
Federal Commercialization Partners USA™ was established as a sister company to CSQ Bio®, extending that commercialization experience into a dedicated organization focused specifically on government healthcare markets.
Alyssa’s leadership philosophy is rooted in building strong partnerships, creating sustainable sales infrastructure and connecting meaningful healthcare innovation with the providers and patients who can benefit from it.